Suchergebnisse - "Pelletier, Elise M"

PubPharm (34)

1

A pooled analysis of exenatide use and risk of acute pancreatitis

enthalten in: Current medical research and opinion | 2013

von Dore, D. | Hussein, M. | Hoffman, C. | +3

2

A pooled analysis of exenatide use and risk of acute pancreatitis

enthalten in: Current medical research and opinion | 2013

von Dore, D. | Hussein, M. | Hoffman, C. | +3

3

Patient out-of-pocket payments for oral oncolytics : results from a 2009 US claims data analysis

enthalten in: The American journal of managed care | 2012

von Raborn, M. | Pelletier, E. | Smith, D. | +1

4

Patient Out-of-Pocket Payments for Oral Oncolytics : Results From a 2009 US Claims Data Analysis

enthalten in: Journal of oncology practice | 2012

von Raborn, M. | Pelletier, E. | Smith, D. | +1

5

Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States : results from a retrospective claims database analysis

enthalten in: Journal of medical economics | 2012

von Pelletier, E. | Pawaskar, M. | Smith, P. | +2

6

Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies : a retrospective analysis of the LifeLink database

enthalten in: Diabetes care | 2011

von Best, J. | Hoogwerf, B. | Herman, W. | +4

7

Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database

enthalten in: Diabetes care | 2011

von Best, J. | Hoogwerf, B. | Herman, W. | +4

8

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis : results from an analysis of data from a US claims database

enthalten in: Clinical therapeutics | 2009

von Pelletier, E. | Ogale, S. | Yu, E. | +2

9

Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?

enthalten in: Patient preference and adherence | 2009

von Chapman, R. | Pelletier, E. | Smith, P. | +1

10

The FDA's critical path initiative: A brief introduction

enthalten in: Clinical therapeutics | 2009

von Pelletier, E. | Ogale, S. | Yu, E. | +2